<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13259">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01885507</url>
  </required_header>
  <id_info>
    <org_study_id>RC13_0127</org_study_id>
    <nct_id>NCT01885507</nct_id>
  </id_info>
  <brief_title>Mechanical Ventilation in Brain-injured Patients</brief_title>
  <acronym>BI-VILI</acronym>
  <official_title>Duration of Mechanical Ventilation and Mortality Among Brain-injured Patients - a Before-after Evaluation of a Quality Improvement Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <authority>France: Institutional Ethical Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Protective ventilation (association of a tidal volume &lt; 8 ml/kg with a positive end
      expiratory pressure) is poorly used in severe brain-injured patients. Moreover, a systematic
      approach to extubation may decrease the rate of extubation failure and enhance outcomes of
      brain-injured patients.

      We hypothesized that medical education and implementation of an evidence-base care bundle
      associating protective ventilation and systemic approach to extubation can reduce the
      duration of mechanical ventilation in brain-injured patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A before/after study design will be used. The before period (control phase) will consisted
      of all consecutive patients with severe brain-injury who were admitted to the participating
      ICUs.

      During the interphase, all physicians, residents, physiotherapists and nurses will receive a
      formal training for the processes and procedures related to the 2 point bundle: protective
      ventilation and systematic approach to extubation (according to recommendation for the use
      of tidal volume &lt; 7 ml/kg and of a positive expiratory pressure = 6 to 8 cmH20 (centimeter
      of water) and extubation as soon as ventilatory weaning is associated with a glasgow coma
      scale equal or above 10 and cought).

      The after period consisted of all consecutive severe brain-injured patients admitted to the
      participating ICUs after the formal training.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Mechanical ventilatory free days</measure>
    <time_frame>Day-90</time_frame>
    <safety_issue>No</safety_issue>
    <description>The number of ventilator-free days was defined as the number of days from day 1 to day 90 on which a patient breaths spontaneously and is alive</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>day-90</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-ICU mortality</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU free days at day 90</measure>
    <time_frame>day 90</time_frame>
    <safety_issue>No</safety_issue>
    <description>The number of ICU free days was defined as the number of days from day 1 to on which a patient is alive and not hospitalized in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute respiratory distress syndrome / acute lung injury</measure>
    <time_frame>day-90</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital acquired pneumonia</measure>
    <time_frame>day-90</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gaz</measure>
    <time_frame>day-5</time_frame>
    <safety_issue>No</safety_issue>
    <description>PaO2 (arterial pressure of oxygen) and PaCO2 (arterial pressure of dioxide of carbon)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intracranial pressure</measure>
    <time_frame>day-5</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow outcome scale</measure>
    <time_frame>day-90</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extubation failure</measure>
    <time_frame>day-90</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilatory setting</measure>
    <time_frame>day-5</time_frame>
    <safety_issue>No</safety_issue>
    <description>Tidal volume and Positive end expiratory pressure</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">560</enrollment>
  <condition>Brain-injury</condition>
  <condition>Stroke</condition>
  <condition>Subarachnoid Haemorrhage</condition>
  <condition>Traumatic Brain Injury</condition>
  <condition>Structural Coma</condition>
  <arm_group>
    <arm_group_label>Control phase (before)</arm_group_label>
    <description>Process of care and outcomes before the educational program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training phase (after)</arm_group_label>
    <description>Process of care and outcomes after the educational program which recommends:
the use of tidal volume &lt; 7 ml/kg and of a positive expiratory pressure = 6 to 8 cmH20 (centimeter of water)
extubation as soon as ventilatory weaning is associated with a glasgow coma scale equal or above 10 and cough</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Structural coma.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (traumatic brain-injured, subarachnoid hemorrhage, stroke or other)

          -  Brain injury (Glasgow Coma Scale ≤ 12 associated with at least one anomaly related to
             an acute process on head tomographic tomodensitometry

          -  mechanical ventilation for more than 24 hours

        Exclusion Criteria:

          -  early decision to withdraw care (taken in the first 24 hours in ICU),

          -  death in the first 24 hours
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Antoine Roquilly, MD</last_name>
    <phone>3240083005</phone>
    <email>antoine.roquilly@chu-nantes.Fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Angers University Hospital</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sigismond Lasocki, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Sigismond Lasocki, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beaujon Hospital</name>
      <address>
        <city>Beaujon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine Paugam, PhD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Catherine Paugam, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brest University Hospital</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascale Le Maguet, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pascale Le Maguet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean Luc Hanouz, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jean Luc Hanouz</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume Zamparini, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clermont-Ferrand University Hospital</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel Constantin, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Michel Constantin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Russel Chabanne</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henri Mondor University Hospital</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice Cook, MD</last_name>
    </contact>
    <investigator>
      <last_name>Fabrice Cook, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthieu Martin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-François Payen, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-François Payen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bicêtre University Hospital</name>
      <address>
        <city>Le Kremlin Bicêtre</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacques Duranteau, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jacques Duranteau, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marseille University Hospital</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Leone, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Marc Leone, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuelle Hammad, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montpellier University Hospital</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Francois Perrigault, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pierre Francois Perrigault, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karim Asehnoune, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Karim Asehnoune, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nice University Hospital</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole Ichai, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Carole Ichai, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nimes University Hospital</name>
      <address>
        <city>Nime</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Muller, MD</last_name>
    </contact>
    <investigator>
      <last_name>Laurent Muller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georges Pompidou European Hospital</name>
      <address>
        <city>Pars</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier Journois, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Didier Journois, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Poitiers University Hospital</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Mimoz, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Olivier Mimoz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire Dahyot, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire Pichot</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yannick Malledant, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Yannick Malledant, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe Seguin, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benoit Veber, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Benoit Veber, PD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Saint Herblain</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand Rozec, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bertrand Rozec, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toulouse University Hospital - Rangueil</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Segolene Mrozek, MD</last_name>
    </contact>
    <investigator>
      <last_name>Segolene Mrozek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toulouse University Hospital - Purpan</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas GEERRAERTS, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Thomas GEERRAERTS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fouad Marhar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tours University Hospital - Neurotrauma ICU</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Damien Bresson, MD</last_name>
    </contact>
    <investigator>
      <last_name>Damien Bresson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tours Univeristy Hospital - Neurosurgery ICU</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martine Ferrandiere, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marc Laffon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Djilali Elaroussi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 8, 2013</lastchanged_date>
  <firstreceived_date>June 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
